-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ShOVxD7qNys2SUiK7PqDxmm1dMUAKOdjE/CeB/qpbBsGB28gxly4fMVa0SbAS/qV B48o1uXQPL08A0X+ciZ6tA== 0001144204-07-066040.txt : 20071205 0001144204-07-066040.hdr.sgml : 20071205 20071205213340 ACCESSION NUMBER: 0001144204-07-066040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071203 FILED AS OF DATE: 20071205 DATE AS OF CHANGE: 20071205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RICHARDSON DALE L CENTRAL INDEX KEY: 0001162527 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 071288026 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 9252494000 4 1 v096415_ex.xml X0202 4 2007-12-03 0 0000071478 LIPID SCIENCES INC/ LIPD 0001162527 RICHARDSON DALE L 7068 KOLL CENTER PARKWAY, SUITE 401 PLEASANTON CA 94566 0 1 0 0 VP, Business Development Stock Option (right to buy) 3.21 2007-12-03 4 D 0 155902 D 2010-07-25 Common Stock 155902 0 D Stock Option (right to buy) 0.89 2007-12-03 4 A 0 155902 D 2010-07-25 Common Stock 155902 155902 D Stock Option (right to buy) 3.70 2007-12-03 4 D 0 36054 D 2015-03-09 Common Stock 36054 0 D Stock Option (right to buy) 0.89 2007-12-03 4 A 0 36054 D 2015-03-09 Common Stock 36054 36054 D Stock Option (right to buy) 2.64 2007-12-03 4 D 0 28044 D 2016-02-27 Common Stock 28044 0 D Stock Option (right to buy) 0.89 2007-12-03 4 A 0 28044 D 2016-02-27 Common Stock 28044 28044 D The six reported transactions involved an amendment of three outstanding options, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The options were originally granted on July 26, 2000, March 10, 2005 and February 28, 2006. The options vested as to 1/8th of the total grant on the first date following six months of continuous employment with the Company and the remaining option shares vested at the rate of 1/48th of the total option shares per month thereafter for the next 42 months. The option fully vested on February 28, 2006 in connection with approval by the Federal Drug Administration of the Company's Investigational Device Exemption relating to HDL Selective Delipidation. The option with respect to 1/3rd of the shares vests in equal installments on the 1st, 2nd and 3rd annual anniversaries of the grant date. /s/ Dale L. Richardson 2007-12-05 -----END PRIVACY-ENHANCED MESSAGE-----